ISIN | CH0506063244 |
---|---|
Valor Number | 50606324 |
Bloomberg Global ID | |
Fund Name | UBAM (CH) - Swiss Equity (CHF) I |
Fund Provider |
Union Bancaire Privée, UBP SA
Genève 1, Switzerland Phone: +41 22 819 28 00 E-Mail: ubpfunds@ubp.com Web: www.ubp.com |
Fund Provider | Union Bancaire Privée, UBP SA |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Swiss Equity sub-fund aims in the medium term, to generate superior returns relative to the Swiss equity market as measured by the SPI® index. The sub-fund is actively managed and the companies are chosen after a rigorous and diverse selection process. No guarantee can be given as to the achievement of the sub-fund's investment objective. |
Peculiarities |
Current Price * | 112.49 CHF | 08.05.2025 |
---|---|---|
Previous Price * | 112.44 CHF | 07.05.2025 |
52 Week High * | 117.40 CHF | 03.03.2025 |
52 Week Low * | 98.39 CHF | 09.04.2025 |
NAV * | 112.49 CHF | 08.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 12,688,534 | |
Unit/Share Assets *** | 12,335,280 | |
Trading Information SIX |
YTD Performance | +4.58% |
31.12.2024 - 08.05.2025
31.12.2024 08.05.2025 |
---|---|---|
1 month | +10.04% |
08.04.2025 - 08.05.2025
08.04.2025 08.05.2025 |
3 months | -2.42% |
10.02.2025 - 08.05.2025
10.02.2025 08.05.2025 |
6 months | +1.65% |
08.11.2024 - 08.05.2025
08.11.2024 08.05.2025 |
1 year | +4.98% |
08.05.2024 - 08.05.2025
08.05.2024 08.05.2025 |
2 years | +7.72% |
08.05.2023 - 08.05.2025
08.05.2023 08.05.2025 |
3 years | +8.84% |
09.05.2022 - 08.05.2025
09.05.2022 08.05.2025 |
5 years | +22.51% |
08.05.2020 - 08.05.2025
08.05.2020 08.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 11.40% | |
---|---|---|
Nestle SA | 8.96% | |
Novartis AG Registered Shares | 8.42% | |
UBS Group AG | 6.93% | |
ABB Ltd | 6.44% | |
Zurich Insurance Group AG | 5.03% | |
Alcon Inc | 3.87% | |
Swiss Re AG | 3.56% | |
Lonza Group Ltd | 3.35% | |
Partners Group Holding AG | 2.87% | |
Last data update | 31.01.2025 |
TER | 0.90% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |